Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Avantor, Inc. (AVTR)
USD11.27
-0.03 (-0.22%)
US NYSE Healthcare Medical - Instruments & Supplies
Address
Radnor Corporate Center 19087
Radnor, PA, US
Radnor, PA, US
CEO
Emmanuel Ligner
Website
avantorsciences.com
IPO
2019-05-17
CIK 1722482 ISIN US05352A1007
Also trades on
New York Stock Exchange · AVTR (USD)
New York Stock Exchange · AVTR-PA (USD)
Description
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
News Sentiment (7d)
Based on only 1 article — low confidence
- Here's Why You Should Hold Avantor Stock in Your Portfolio for Now Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD11.27
-0.03 (-0.22%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
10M
Beta
0.96
Float Shares
661.84M
Free Float %
96.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.33% | +12.87% | +12.59% | +0.77% | -22.25% | -20.42% | -29.36% | -55.69% | -70.91% | -37.10% | -37.10% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (26 ratings, all time)
Hold
Price Targets & DCF
Current price
11.27
Low
7.00
-37.9%
Consensus
9.44
-16.2%
Median
10.00
-11.2%
High
11.00
-2.4%
DCF (Unlevered)
29.68
+163.5%
DCF (Levered)
21.85
+93.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
19% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 11 | -1 |
| Sell | 1 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
9.00
-20.1%
|
| Last Quarter | 2 |
8.00
-29.0%
|
| Last Year | 16 |
10.66
-5.4%
|
| All Time | 38 |
22.59
+100.5%
|
Quality scores
Altman Z-Score
1.19
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-3.4% Q1'26: +0.0% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-175.0% Q1'26: -32.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-6.8% Q1'26: +1.6% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-4.1% Q1'26: +7.3% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%-3.0% Q1'26: +6.7% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-0.4% ★ Q1'26: -0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×28.45× Q1'26: 0.04× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 12 Rev. Ana. 9 EPS Ana. |
Dec 2027 12 Rev. Ana. 9 EPS Ana. |
Dec 2028 9 Rev. Ana. 2 EPS Ana. |
Dec 2029 4 Rev. Ana. 1 EPS Ana. |
Dec 2030 4 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.04B
est: 6.04B (0.0%)
|
6.39B
est: 6.29B (+1.6%)
|
7.39B
est: 7.38B (+0.1%)
|
7.51B
est: 7.51B (0.0%)
|
6.97B
est: 6.83B (+2.1%)
|
6.78B
est: 6.81B (-0.4%)
|
6.55B
est: 6.53B (+0.4%)
|
6.50B
6.48B – 6.52B
-0.4% YoY
|
6.64B
6.59B – 6.75B
+2.1% YoY
|
6.85B
6.85B – 6.86B
+3.2% YoY
|
7.10B
7.04B – 7.16B
+3.5% YoY
|
7.37B
7.32B – 7.44B
+3.9% YoY
|
| EBITDA |
879.50M
est: 1.06B (-17.4%)
|
765.30M
est: 605.92M (+26.3%)
|
1.35B
est: 949.73M (+42.1%)
|
1.52B
est: 1.20B (+26.5%)
|
1.10B
est: 1.07B (+2.8%)
|
1.48B
est: 1.06B (+38.8%)
|
138.70M
est: 1.02B (-86.4%)
|
1.02B
1.01B – 1.02B
-0.4% YoY
|
1.04B
1.03B – 1.06B
+2.1% YoY
|
1.07B
1.07B – 1.07B
+3.2% YoY
|
1.11B
1.10B – 1.12B
+3.5% YoY
|
1.15B
1.14B – 1.16B
+3.9% YoY
|
| EBIT |
480.60M
est: 720.10M (-33.3%)
|
369.90M
est: 577.26M (-35.9%)
|
970.40M
est: 821.48M (+18.1%)
|
1.12B
est: 1.04B (+7.0%)
|
695.30M
est: 677.85M (+2.6%)
|
1.07B
est: 676.13M (+58.7%)
|
-271.50M
est: 648.14M (-141.9%)
|
645.71M
643.72M – 647.70M
-0.4% YoY
|
659.36M
654.35M – 670.36M
+2.1% YoY
|
680.72M
680.37M – 681.08M
+3.2% YoY
|
704.77M
699.58M – 711.22M
+3.5% YoY
|
732.01M
726.62M – 738.71M
+3.9% YoY
|
| Net Income |
37.80M
est: 378.75M (-90.0%)
|
116.60M
est: 88.91M (+31.1%)
|
572.60M
est: 482.05M (+18.8%)
|
686.50M
est: 607.26M (+13.0%)
|
321.10M
est: 360.20M (-10.9%)
|
711.50M
est: 666.64M (+6.7%)
|
-530.20M
est: 611.88M (-186.7%)
|
535.47M
528.69M – 542.24M
-12.5% YoY
|
579.92M
552.30M – 607.53M
+8.3% YoY
|
620.75M
529.73M – 711.78M
+7.0% YoY
|
669.11M
662.70M – 677.07M
+7.8% YoY
|
706.47M
699.71M – 714.87M
+5.6% YoY
|
| SGA |
1.37B
est: 1.30B (+5.2%)
|
1.37B
est: 1.12B (+22.5%)
|
1.53B
est: 1.31B (+17.1%)
|
1.47B
est: 1.53B (-4.0%)
|
1.51B
est: 1.51B (-0.1%)
|
1.64B
est: 1.50B (+9.1%)
|
1.60B
est: 1.44B (+10.6%)
|
1.44B
1.43B – 1.44B
-0.4% YoY
|
1.47B
1.46B – 1.49B
+2.1% YoY
|
1.51B
1.51B – 1.52B
+3.2% YoY
|
1.57B
1.56B – 1.58B
+3.5% YoY
|
1.63B
1.62B – 1.64B
+3.9% YoY
|
| EPS |
-0.84
est: 0.56 (-251.2%)
|
0.09
est: 0.87 (-89.6%)
|
0.86
est: 1.39 (-38.0%)
|
1.02
est: 1.39 (-26.7%)
|
0.48
est: 0.53 (-9.7%)
|
1.05
est: 0.98 (+7.0%)
|
-0.78
est: 0.90 (-186.6%)
|
0.79
0.78 – 0.80
-12.5% YoY
|
0.85
0.81 – 0.89
+8.3% YoY
|
0.91
0.78 – 1.05
+7.0% YoY
|
0.99
0.98 – 1.00
+7.8% YoY
|
1.04
1.03 – 1.05
+5.6% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-30 | Citigroup | Neutral | Neutral | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-27 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-26 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-22 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-05 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
425.63M
OE per share TTM
0.63
Owner's Yield
6.88%
Maintenance CapEx ratio
77.37%
Maint CapEx / Avg PPE
10.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
442
Total invested
5.30B
Insider transactions (90d)
11
Beneficial owners (>5%)
19
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 85-4328500 | 69.07M | 10.20% | 22.68M | — | 69.07M | — | IA | Maryland | 2022-11-10 | ↗ |
| 2 | Cox 94-1441976 | 61.20M | 9.00% | 57.55M | — | 61.20M | — | IA | — | 2024-02-13 | ↗ |
| 3 | The Vanguard Group - 23-1945930 | 50.32M | 8.26% | — | 555.7K | 49.04M | 1.28M | IA | Pennsylvania | 2022-02-09 | ↗ |
| 4 | 52-0556948 | 43.92M | 6.50% | 20.84M | — | 43.92M | — | IA | Maryland | 2022-08-10 | ↗ |
| 5 | (1) BlackRock, Inc. | 43.77M | 7.10% | 40.31M | — | 43.77M | — | HC | Delaware | 2022-03-11 | ↗ |
| 6 | Bridge Street Opportunity Advisors, L.L.C. | 32.97M | 5.70% | — | 32.97M | — | 32.97M | OO | — | 2021-05-07 | ↗ |
| 7 | VWR Partners, L.P. | 29.01M | 5.00% | — | 29.01M | — | 29.01M | PN | — | 2021-05-07 | ↗ |
| 8 | L.L.C. | 28.00M | 4.80% | — | 28.00M | — | 28.00M | OO | — | 2021-02-16 | ↗ |
| 9 | L.P. | 28.00M | 4.80% | — | 28.00M | — | 28.00M | PN | — | 2021-02-16 | ↗ |
| 10 | NM Holdings GP, L.L.C. | 28.00M | 4.80% | — | 28.00M | — | 28.00M | OO | — | 2021-02-16 | ↗ |
| 11 | Steven B. Klinsky | 28.00M | 4.80% | — | 28.00M | — | 28.00M | IN | — | 2021-02-16 | ↗ |
| 12 | Goldman Sachs & Co. LLC | 27.48M | 4.80% | — | 27.48M | — | 27.48M | BD, IA, PN | — | 2021-05-07 | ↗ |
| 13 | The Goldman Sachs Group, Inc. | 27.48M | 4.80% | — | 27.48M | — | 27.48M | HC, CO | — | 2021-05-07 | ↗ |
| 14 | 98-0557567 | 25.42M | 4.20% | 24.27M | — | 25.42M | — | IA, HC | Bermuda | 2022-01-31 | ↗ |
| 15 | Broad Street Principal Investments, L.L.C. | 2.63M | 0.50% | — | 2.63M | — | 2.63M | OO | — | 2021-05-07 | ↗ |
| 16 | StoneBridge 2018, L.P. | 1.57M | 0.30% | — | 1.57M | — | 1.57M | PN | — | 2021-05-07 | ↗ |
| 17 | StoneBridge 2018 Offshore, L.P. | 879.0K | 0.20% | — | 879.0K | — | 879.0K | PN | — | 2021-05-07 | ↗ |
| 18 | StoneBridge 2017, L.P. | 512.4K | 0.10% | — | 512.4K | — | 512.4K | PN | — | 2021-05-07 | ↗ |
| 19 | StoneBridge 2017 Offshore, L.P. | 315.8K | 0.10% | — | 315.8K | — | 315.8K | PN | — | 2021-05-07 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
442
+1 vs prev Q
New positions
89
Closed positions
83
Increased
257
Reduced
126
Put/Call ratio
19.10
Calls held
481.8K
Puts held
9.20M
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | DODGE & COX | 117.07M -681.7K (-0.6%) | 1.34B -127.9M (-8.7%) | 17.27% -0.011 pp | 0.72% -0.069 pp | USD20.82 -45.0% | 10 qtrs — |
| 2 | VANGUARD GROUP INC | 64.90M -1.1M (-1.6%) | 743.81M -79.7M (-9.7%) | 9.57% -0.110 pp | 0.01% -0.002 pp | USD21.75 -47.3% | 27 qtrs — |
| 3 | BLACKROCK, INC. | 59.60M -1.1M (-1.8%) | 682.98M -74.8M (-9.9%) | 8.79% -0.119 pp | 0.01% -0.002 pp | USD25.63 -55.3% | 6 qtrs — |
| 4 | BARROW HANLEY MEWHINNEY & STRAUSS LLC | 33.29M -1.3M (-3.6%) | 381.47M -49.7M (-11.5%) | 4.88% -0.187 pp | 1.27% -0.103 pp | USD20.22 -43.3% | 12 qtrs — |
| 5 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 32.13M -795.9K (-2.4%) | 368.23M -42.7M (-10.4%) | 4.74% -0.092 pp | 0.23% -0.019 pp | USD18.41 -37.8% | 14 qtrs — |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 23.44M +23.4M (+100.0%) | 268.58M +268.6M (+100.0%) | 3.44% +3.438 pp | 0.05% +0.047 pp | USD11.46 +0.0% | 21 qtrs — |
| 7 | GREENHAVEN ASSOCIATES INC | 20.50M +2.2M (+12.0%) | 234.94M +6.4M (+2.8%) | 3.01% +0.320 pp | 3.81% +0.332 pp | USD12.37 -7.4% | 2 qtrs — |
| 8 | STATE STREET CORP | 20.21M -156.4K (-0.8%) | 231.60M -22.6M (-8.9%) | 2.98% -0.008 pp | 0.01% -0.001 pp | USD23.21 -50.6% | 27 qtrs — |
| 9 | MORGAN STANLEY | 17.47M +11.2M (+179.4%) | 200.19M +122.2M (+156.6%) | 2.58% +1.659 pp | 0.01% +0.007 pp | USD15.44 -25.8% | 27 qtrs — |
| 10 | INVESCO LTD. | 17.18M +1.1M (+7.0%) | 196.87M -3.5M (-1.7%) | 2.53% +0.178 pp | 0.03% -0.001 pp | USD17.81 -35.7% | 27 qtrs — |
| 11 | CLARKSTON CAPITAL PARTNERS, LLC | 15.11M +84.7K (+0.6%) | 173.10M -14.3M (-7.7%) | 2.22% +0.012 pp | 4.01% -0.030 pp | USD18.21 -37.1% | 12 qtrs — |
| 12 | DIMENSIONAL FUND ADVISORS LP | 14.61M +1.2M (+9.1%) | 167.39M +390.8K (+0.2%) | 2.14% +0.179 pp | 0.04% -0.001 pp | USD18.32 -37.4% | 26 qtrs — |
| 13 | NEW MOUNTAIN CAPITAL, L.L.C. | 14.00M +— (+0.0%) | 160.44M -14.3M (-8.2%) | 2.05% -0.001 pp | 100.00% +0.000 pp | USD19.60 -41.5% | 14 qtrs — |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 11.98M -317.1K (-2.6%) | 137.31M -16.2M (-10.5%) | 1.77% -0.038 pp | 0.01% -0.001 pp | USD23.09 -50.4% | 27 qtrs — |
| 15 | LONDON CO OF VIRGINIA | 11.94M -857.4K (-6.7%) | 136.79M -22.9M (-14.3%) | 1.76% -0.117 pp | 0.79% -0.092 pp | USD12.48 -8.2% | 2 qtrs — |
| 16 | ENGINE CAPITAL MANAGEMENT, LP | 11.93M -7.8M (-39.5%) | 136.69M -109.4M (-44.5%) | 1.76% -1.134 pp | 18.87% -10.349 pp | USD12.75 -10.1% | 3 qtrs — |
| 17 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 8.73M -3.3M (-27.3%) | 100.10M -49.7M (-33.2%) | 1.28% -0.481 pp | 0.08% -0.041 pp | USD20.41 -43.9% | 26 qtrs — |
| 18 | UBS GROUP AG | 7.73M +3.6M (+86.0%) | 88.60M +36.7M (+70.8%) | 1.14% +0.530 pp | 0.01% +0.006 pp | USD15.09 -24.1% | 27 qtrs — |
| 19 | FMR LLC | 7.67M +48.9K (+0.6%) | 87.91M -7.2M (-7.6%) | 1.13% +0.007 pp | 0.00% -0.001 pp | USD17.90 -36.0% | 27 qtrs — |
| 20 | ROBECO SCHWEIZ AG | 7.28M -639.2K (-8.1%) | 83.44M -15.4M (-15.6%) | 1.07% -0.094 pp | 1.87% -0.353 pp | USD29.12 -60.6% | 18 qtrs — |
| 21 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 7.21M -287.7K (-3.8%) | 82.68M -10.9M (-11.7%) | 1.06% -0.043 pp | 0.03% -0.002 pp | USD13.25 -13.5% | 3 qtrs — |
| 22 | NORGES BANK | 6.40M +6.4M (+100.0%) | 73.32M +73.3M (+100.0%) | 0.94% +0.939 pp | 0.01% +0.008 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 23 | D. E. SHAW & CO., INC. | 6.22M +4.8M (+350.2%) | 71.23M +54.0M (+313.4%) | 0.91% +0.709 pp | 0.04% +0.029 pp | USD11.72 -2.2% | 26 qtrs — |
| 24 | EARNEST PARTNERS LLC | 6.03M -164.9K (-2.7%) | 69.12M -8.2M (-10.6%) | 0.88% -0.025 pp | 0.30% -0.039 pp | USD13.44 -14.7% | 3 qtrs — |
| 25 | BANK OF AMERICA CORP /DE/ | 5.69M -1.3M (-18.4%) | 65.15M -21.8M (-25.1%) | 0.84% -0.184 pp | 0.00% -0.001 pp | USD17.90 -36.0% | 27 qtrs — |
| 26 | NORTHERN TRUST CORP | 5.31M -251.6K (-4.5%) | 60.85M -8.6M (-12.3%) | 0.78% -0.037 pp | 0.01% -0.001 pp | USD21.84 -47.5% | 27 qtrs — |
| 27 | SEI INVESTMENTS CO | 5.24M +677.7K (+14.9%) | 60.06M +3.1M (+5.5%) | 0.77% +0.099 pp | 0.06% -0.002 pp | USD16.33 -29.8% | 27 qtrs — |
| 28 | VOYA INVESTMENT MANAGEMENT LLC | 4.96M -6.1K (-0.1%) | 56.86M -5.1M (-8.3%) | 0.73% -0.001 pp | 0.06% -0.006 pp | USD20.92 -45.2% | 26 qtrs — |
| 29 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.88M +151.1K (+3.2%) | 55.92M -3.1M (-5.2%) | 0.72% +0.022 pp | 0.01% -0.001 pp | USD18.90 -39.4% | 27 qtrs — |
| 30 | BANK OF NEW YORK MELLON CORP | 4.42M +93.2K (+2.2%) | 50.63M -3.3M (-6.2%) | 0.65% +0.014 pp | 0.01% -0.002 pp | USD22.44 -48.9% | 27 qtrs — |
| 31 | AQR CAPITAL MANAGEMENT LLC | 4.39M +3.2M (+263.2%) | 50.33M +36.0M (+252.3%) | 0.64% +0.467 pp | 0.03% +0.017 pp | USD12.49 -8.2% | 22 qtrs — |
| 32 | VOSS CAPITAL, LLC | 4.10M -422.2K (-9.3%) | 47.02M -9.5M (-16.7%) | 0.61% -0.059 pp | 2.26% -0.476 pp | USD12.58 -8.9% | 3 qtrs — |
| 33 | FIRST PACIFIC ADVISORS, LP | 3.97M -102.4K (-2.5%) | 45.48M -5.3M (-10.5%) | 0.58% -0.015 pp | 0.60% -0.104 pp | USD12.50 -8.3% | 3 qtrs — |
| 34 | JANE STREET GROUP, LLC | 3.83M +3.8M (+12,256.3%) | 43.91M +43.5M (+11,246.4%) | 0.57% +0.561 pp | 0.01% +0.007 pp | USD11.47 -0.1% | 2 qtrs — |
| 35 | MILLENNIUM MANAGEMENT LLC | 3.67M +966.5K (+35.8%) | 42.05M +8.3M (+24.7%) | 0.54% +0.145 pp | 0.02% +0.003 pp | USD12.22 -6.2% | 27 qtrs — |
| 36 | AMERIPRISE FINANCIAL INC | 3.63M +2.1M (+141.8%) | 41.55M +22.8M (+122.0%) | 0.53% +0.312 pp | 0.01% +0.005 pp | USD16.29 -29.7% | 27 qtrs — |
| 37 | ASSENAGON ASSET MANAGEMENT S.A. | 3.62M +3.6M (+100.0%) | 41.49M +41.5M (+100.0%) | 0.53% +0.531 pp | 0.06% +0.057 pp | USD11.46 +0.0% | 16 qtrs — |
| 38 | SOUTHEASTERN ASSET MANAGEMENT INC/TN/ | 3.55M -1.6M (-31.1%) | 40.67M -23.6M (-36.7%) | 0.52% -0.232 pp | 1.81% -1.469 pp | USD12.48 -8.2% | 2 qtrs — |
| 39 | BRICKWOOD ASSET MANAGEMENT LLP | 3.18M +3.1M (+6,891.9%) | 36.49M +35.9M (+6,320.4%) | 0.47% +0.460 pp | 25.39% +24.989 pp | USD11.47 -0.1% | 2 qtrs — |
| 40 | EVERSEPT PARTNERS, LP | 3.18M +2.3M (+243.6%) | 36.40M +24.9M (+215.5%) | 0.47% +0.333 pp | 1.83% +1.039 pp | USD12.26 -6.5% | 21 qtrs — |
| 41 | FREESTONE GROVE PARTNERS LP | 2.58M +2.6M (+100.0%) | 29.61M +29.6M (+100.0%) | 0.38% +0.381 pp | 0.21% +0.214 pp | USD11.46 +0.0% | 5 qtrs — |
| 42 | PRIVATE MANAGEMENT GROUP INC | 2.46M +823.6K (+50.4%) | 28.16M +7.8M (+38.1%) | 0.36% +0.121 pp | 0.82% +0.213 pp | USD12.68 -9.6% | 3 qtrs — |
| 43 | TD ASSET MANAGEMENT INC | 2.29M -171.0K (-6.9%) | 26.27M -4.5M (-14.5%) | 0.34% -0.025 pp | 0.02% -0.004 pp | USD27.06 -57.6% | 26 qtrs — |
| 44 | NATIXIS ADVISORS, L.P. | 2.12M +214.7K (+11.3%) | 24.32M +516.0K (+2.2%) | 0.31% +0.031 pp | 0.03% 0.000 pp | USD13.98 -18.0% | 25 qtrs — |
| 45 | FIRST TRUST ADVISORS LP | 2.11M -579.9K (-21.5%) | 24.24M -9.4M (-27.9%) | 0.31% -0.084 pp | 0.02% -0.007 pp | USD14.12 -18.8% | 27 qtrs — |
| 46 | UBS ASSET MANAGEMENT AMERICAS INC | 2.09M -288.4K (-12.1%) | 23.98M -5.7M (-19.3%) | 0.31% -0.042 pp | 0.01% -0.001 pp | USD22.06 -48.1% | 26 qtrs — |
| 47 | CITIGROUP INC | 2.00M -1.1M (-34.8%) | 22.94M -15.4M (-40.2%) | 0.29% -0.157 pp | 0.01% -0.007 pp | USD17.10 -33.0% | 27 qtrs — |
| 48 | PERPETUAL LTD | 1.83M +28.3K (+1.6%) | 21.00M -1.5M (-6.7%) | 0.27% +0.004 pp | 0.30% +0.024 pp | USD21.41 -46.5% | 12 qtrs — |
| 49 | FRONTIER CAPITAL MANAGEMENT CO LLC | 1.81M -732.1K (-28.8%) | 20.77M -11.0M (-34.6%) | 0.27% -0.106 pp | 0.22% -0.064 pp | USD15.45 -25.8% | 12 qtrs — |
| 50 | NEW SOUTH CAPITAL MANAGEMENT INC | 1.81M -18.2K (-1.0%) | 20.76M -2.1M (-9.1%) | 0.27% -0.003 pp | 0.96% -0.086 pp | USD13.84 -17.2% | 24 qtrs — |
| 51 | TUDOR INVESTMENT CORP ET AL | 1.81M +1.8M (+13,600.0%) | 20.72M +20.6M (+12,480.3%) | 0.27% +0.263 pp | 0.04% +0.038 pp | USD11.47 -0.1% | 3 qtrs — |
| 52 | ZUCKERMAN INVESTMENT GROUP, LLC | 1.75M +26.0K (+1.5%) | 20.05M -1.5M (-6.8%) | 0.26% +0.005 pp | 1.79% -0.201 pp | USD18.28 -37.3% | 14 qtrs — |
| 53 | RHUMBLINE ADVISERS | 1.66M -77.9K (-4.5%) | 18.99M -2.7M (-12.3%) | 0.24% -0.010 pp | 0.02% -0.002 pp | USD23.67 -51.6% | 26 qtrs — |
| 54 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.62M +1.6M (+100.0%) | 18.59M +18.6M (+100.0%) | 0.24% +0.239 pp | 0.06% +0.063 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 55 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.57M -1.5M (-48.9%) | 18.02M -20.4M (-53.1%) | 0.23% -0.221 pp | 0.12% -0.131 pp | USD18.44 -37.9% | 14 qtrs — |
| 56 | PRINCIPAL FINANCIAL GROUP INC | 1.47M -47.2K (-3.1%) | 16.80M -2.1M (-11.0%) | 0.22% -0.007 pp | 0.01% -0.001 pp | USD25.69 -55.4% | 25 qtrs — |
| 57 | DEKABANK DEUTSCHE GIROZENTRALE | 628.1K +— (+0.0%) | 16.63M +9.3M (+127.6%) | 0.09% +0.001 pp | 0.03% +0.016 pp | USD20.89 -45.1% | 23 qtrs — |
| 58 | NUVEEN, LLC | 1.44M +518.4K (+56.0%) | 16.55M +5.0M (+43.3%) | 0.21% +0.077 pp | 0.00% +0.001 pp | USD14.50 -21.0% | 4 qtrs — |
| 59 | WELLS FARGO & COMPANY/MN | 1.36M -390.5K (-22.4%) | 15.54M -6.3M (-28.7%) | 0.20% -0.056 pp | 0.00% -0.001 pp | USD18.41 -37.8% | 27 qtrs — |
| 60 | SWISS NATIONAL BANK | 1.34M +23.5K (+1.8%) | 15.40M -1.1M (-6.5%) | 0.20% +0.003 pp | 0.01% 0.000 pp | USD21.90 -47.7% | 23 qtrs — |
| 61 | RAYMOND JAMES FINANCIAL INC | 1.30M -520.8K (-28.6%) | 14.87M -7.8M (-34.5%) | 0.19% -0.077 pp | 0.00% -0.003 pp | USD19.37 -40.8% | 5 qtrs — |
| 62 | CITADEL ADVISORS LLC | 1.24M -6.7M (-84.4%) | 14.26M -85.2M (-85.7%) | 0.18% -0.986 pp | 0.00% -0.013 pp | USD13.16 -12.9% | 27 qtrs — |
| 63 | JPMORGAN CHASE & CO | 1.19M -613.9K (-34.0%) | 13.67M -8.9M (-39.4%) | 0.18% -0.090 pp | 0.00% -0.001 pp | USD18.99 -39.7% | 27 qtrs — |
| 64 | CAPTION MANAGEMENT, LLC | 1.15M +1.1M (+1,335.0%) | 13.16M +12.2M (+1,217.7%) | 0.17% +0.158 pp | 0.09% +0.082 pp | USD11.53 -0.6% | 6 qtrs — |
| 65 | ALBERTA INVESTMENT MANAGEMENT CORP | 1.11M +1.1M (+100.0%) | 12.73M +12.7M (+100.0%) | 0.16% +0.164 pp | 0.08% +0.075 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 66 | LOEWS CORP | 1.00M -400.0K (-28.6%) | 11.46M -6.0M (-34.4%) | 0.15% -0.058 pp | 0.09% -0.052 pp | USD13.46 -14.9% | 3 qtrs — |
| 67 | LEGAL & GENERAL GROUP PLC | 999.3K -138.2K (-12.2%) | 11.45M -2.7M (-19.3%) | 0.15% -0.020 pp | 0.00% -0.001 pp | USD25.52 -55.1% | 26 qtrs — |
| 68 | WALLEYE CAPITAL LLC | 991.4K -37.8K (-3.7%) | 11.36M -1.5M (-11.5%) | 0.15% -0.006 pp | 0.03% -0.013 pp | USD16.90 -32.2% | 16 qtrs — |
| 69 | BARCLAYS PLC | 967.6K -14.4K (-1.5%) | 11.09M -14.3M (-56.4%) | 0.14% -0.001 pp | 0.00% -0.004 pp | USD18.47 -38.0% | 27 qtrs — |
| 70 | WESTWOOD HOLDINGS GROUP INC | 949.0K +949.0K (+100.0%) | 10.88M +10.9M (+100.0%) | 0.14% +0.140 pp | 0.09% +0.088 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 71 | GOLDMAN SACHS GROUP INC | 933.9K -911.4K (-49.4%) | 10.70M -12.3M (-53.5%) | 0.14% -0.133 pp | 0.00% -0.002 pp | USD21.59 -46.9% | 27 qtrs — |
| 72 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 925.3K -9.2K (-1.0%) | 10.60M -1.1M (-9.1%) | 0.14% -0.001 pp | 0.01% -0.001 pp | USD20.59 -44.3% | 27 qtrs — |
| 73 | STANLEY CAPITAL MANAGEMENT, LLC | 918.5K -400.0K (-30.3%) | 10.53M -5.9M (-36.0%) | 0.13% -0.059 pp | 1.76% -0.948 pp | USD18.34 -37.5% | 11 qtrs — |
| 74 | PROSIGHT MANAGEMENT, LP | 898.5K +898.5K (+100.0%) | 10.30M +10.3M (+100.0%) | 0.13% +0.132 pp | 2.13% +2.128 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 75 | ALLIANCEBERNSTEIN L.P. | 857.5K -1.0K (-0.1%) | 9.83M -887.3K (-8.3%) | 0.13% +0.001 pp | 0.00% 0.000 pp | USD20.72 -44.7% | 27 qtrs — |
| 76 | RETIREMENT SYSTEMS OF ALABAMA | 818.3K -6.0K (-0.7%) | 9.38M -909.2K (-8.8%) | 0.12% -0.001 pp | 0.03% -0.004 pp | USD25.79 -55.6% | 6 qtrs — |
| 77 | OLSTEIN CAPITAL MANAGEMENT, L.P. | 818.0K +24.0K (+3.0%) | 9.37M -535.0K (-5.4%) | 0.12% +0.004 pp | 1.92% +0.052 pp | USD17.23 -33.5% | 12 qtrs — |
| 78 | READYSTATE ASSET MANAGEMENT LP | 813.1K +738.9K (+995.9%) | 9.32M +8.4M (+906.4%) | 0.12% +0.109 pp | 0.38% +0.338 pp | USD11.64 -1.5% | 3 qtrs — |
| 79 | WEISS ASSET MANAGEMENT LP | 755.4K +204.8K (+37.2%) | 8.66M +1.8M (+26.0%) | 0.11% +0.031 pp | 0.12% +0.041 pp | USD12.20 -6.1% | 2 qtrs — |
| 80 | SECTOR GAMMA AS | 695.4K +218.3K (+45.8%) | 7.97M +2.0M (+33.8%) | 0.10% +0.032 pp | 1.82% +0.340 pp | USD12.68 -9.6% | 3 qtrs — |
| 81 | ENVESTNET ASSET MANAGEMENT INC | 658.0K -231.4K (-26.0%) | 7.54M -3.6M (-32.1%) | 0.10% -0.033 pp | 0.00% -0.001 pp | USD20.94 -45.3% | 24 qtrs — |
| 82 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 640.8K -584.0 (-0.1%) | 7.34M -660.9K (-8.3%) | 0.09% 0.000 pp | 0.01% -0.001 pp | USD20.19 -43.2% | 26 qtrs — |
| 83 | CI PRIVATE WEALTH, LLC | 624.6K -2.9M (-82.2%) | 7.16M -36.6M (-83.6%) | 0.09% -0.422 pp | 0.01% -0.059 pp | USD12.59 -9.0% | 6 qtrs — |
| 84 | VERITION FUND MANAGEMENT LLC | 581.3K +218.9K (+60.4%) | 6.66M +2.1M (+47.3%) | 0.09% +0.032 pp | 0.03% +0.008 pp | USD13.21 -13.2% | 25 qtrs — |
| 85 | THORNBURG INVESTMENT MANAGEMENT INC | 577.0K +131.2K (+29.4%) | 6.61M +1.0M (+18.9%) | 0.09% +0.020 pp | 0.08% +0.011 pp | USD24.51 -53.2% | 21 qtrs — |
| 86 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 568.1K -37.0K (-6.1%) | 6.51M -1.0M (-13.8%) | 0.08% -0.006 pp | 0.01% -0.002 pp | USD21.08 -45.6% | 25 qtrs — |
| 87 | PRICE T ROWE ASSOCIATES INC /MD/ | 563.5K +26.0K (+4.8%) | 6.46M -250.0K (-3.7%) | 0.08% +0.004 pp | 0.00% +0.000 pp | USD21.66 -47.1% | 27 qtrs — |
| 88 | GENDELL JEFFREY L | 545.0K +545.0K (+100.0%) | 6.25M +6.2M (+100.0%) | 0.08% +0.080 pp | 0.11% +0.109 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 89 | CAPITOLIS LIQUID GLOBAL MARKETS LLC | 505.0K +505.0K (+100.0%) | 5.79M +5.8M (+100.0%) | 0.07% +0.075 pp | 0.03% +0.035 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 90 | CLEARLINE CAPITAL LP | 502.7K +502.7K (+100.0%) | 5.76M +5.8M (+100.0%) | 0.07% +0.074 pp | 0.28% +0.284 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 91 | MOORE CAPITAL MANAGEMENT, LP | 499.1K +205.5K (+70.0%) | 5.72M +2.1M (+56.1%) | 0.07% +0.031 pp | 0.08% +0.032 pp | USD16.10 -28.8% | 11 qtrs — |
| 92 | TAIKANG ASSET MANAGEMENT (HONG KONG) CO LTD | 486.6K +171.7K (+54.5%) | 5.58M +1.6M (+41.9%) | 0.07% +0.026 pp | 0.55% +0.112 pp | USD12.12 -5.4% | 2 qtrs — |
| 93 | REINHART PARTNERS, INC. | 485.0K -202.8K (-29.5%) | 5.56M -3.0M (-34.9%) | 0.07% -0.030 pp | 0.17% -0.111 pp | USD19.06 -39.9% | 13 qtrs — |
| 94 | STATE OF WISCONSIN INVESTMENT BOARD | 461.9K +3.8K (+0.8%) | 5.29M -423.5K (-7.4%) | 0.07% +0.001 pp | 0.01% -0.001 pp | USD21.95 -47.8% | 26 qtrs — |
| 95 | BOSTON PARTNERS | 433.4K +433.4K (+100.0%) | 4.97M +5.0M (+100.0%) | 0.06% +0.064 pp | 0.01% +0.005 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 96 | AQUATIC CAPITAL MANAGEMENT LLC | 425.8K +425.8K (+100.0%) | 4.88M +4.9M (+100.0%) | 0.06% +0.063 pp | 0.14% +0.139 pp | USD11.46 +0.0% | 1 qtrs NEW |
| 97 | PACIFIC CAPITAL PARTNERS LTD | 424.5K -80.6K (-16.0%) | 4.86M -1.4M (-22.8%) | 0.06% -0.012 pp | 5.17% -1.852 pp | USD19.43 -41.0% | 10 qtrs — |
| 98 | TWO SIGMA INVESTMENTS, LP | 412.7K +129.8K (+45.9%) | 4.73M +1.2M (+34.0%) | 0.06% +0.019 pp | 0.01% +0.001 pp | USD13.64 -16.0% | 6 qtrs — |
| 99 | MACKENZIE FINANCIAL CORP | 412.5K +380.2K (+1,180.2%) | 4.72M +4.3M (+1,074.2%) | 0.06% +0.056 pp | 0.01% +0.005 pp | USD12.12 -5.4% | 21 qtrs — |
| 100 | QUANTINNO CAPITAL MANAGEMENT LP | 406.9K -126.7K (-23.7%) | 4.66M -2.0M (-30.0%) | 0.06% -0.019 pp | 0.01% -0.009 pp | USD15.50 -26.1% | 10 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 150 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Simplify Health Care ETF PINK | 2.04% | 7.80M | 0.51% |
| 2 | Truth Social American Next Frontiers ETF TSNF | 0.74% | 75.7K | 0.65% |
| 3 | Research Affiliates Deletions ETF NIXT | 0.58% | 200.3K | 0.09% |
| 4 | State Street SPDR S&P 400 Mid Cap Value ETF MDYV | 0.41% | 11.23M | 0.15% |
| 5 | iShares S&P Mid-Cap 400 Value ETF IJJ | 0.41% | 35.82M | 0.18% |
| 6 | Dimensional - US Small Cap Value ETF DFSV | 0.41% | 32.66M | 0.30% |
| 7 | Vanguard S&P Mid-Cap 400 Value ETF IVOV | 0.37% | 5.17M | 0.10% |
| 8 | BNY Mellon US Small Cap Core Equity ETF BKSE | 0.30% | 260.6K | 0.04% |
| 9 | Invesco S&P MidCap 400 Revenue ETF RWK | 0.29% | 3.69M | 0.39% |
| 10 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD dis WSCR.L | 0.27% | 2.18M | 0.23% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.54
Bullish
Ratio by volume
3.00
Bullish
Buys
20
Sells
13
Shares acquired
7.09M
Shares disposed
37.5K
Cash buys
3.00
Cash sales
—
Net activity
+7,051,921
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | LUCIER GREGORY T | Director | P-Purchase | A | Common Stock | 10,000 | 8.32 | 83.2K | 60,000 | I | ↗ |
| 2026-05-07 | SUMME GREGORY L | Director | A-Award | A | Common Stock | 25,270 | 0.00 | — | 83,381 | D | ↗ |
| 2026-05-07 | SEVERINO MICHAEL | Director | A-Award | A | Common Stock | 25,270 | 0.00 | — | 85,821 | D | ↗ |
| 2026-05-07 | Murthy Mala | Director | A-Award | A | Common Stock | 25,270 | 0.00 | — | 69,479 | D | ↗ |
| 2026-05-07 | Massaro Joseph R | Director | A-Award | A | Common Stock | 25,270 | 0.00 | — | 77,408 | D | ↗ |
| 2026-05-07 | Makin Louise | Director | A-Award | A | Common Stock | 25,270 | 0.00 | — | 47,140 | D | ↗ |
| 2026-05-07 | MEHRA SANJEEV K | Director | A-Award | A | Common Stock | 25,270 | 0.00 | — | 33,376 | D | ↗ |
| 2026-05-07 | LUCIER GREGORY T | Director | A-Award | A | Common Stock | 25,270 | 0.00 | — | 34,006 | D | ↗ |
| 2026-05-07 | Dingemans Simon | Director | A-Award | A | Common Stock | 25,270 | 0.00 | — | 31,495 | D | ↗ |
| 2026-05-01 | Dingemans Simon | Director | P-Purchase | A | Common Stock | 25,000 | 8.14 | 203.5K | 25,000 | I | ↗ |
| 2026-05-01 | Brellier Ludovic | Officer | A-Award | A | Stock Options (Right to Buy) | 246,002 | 8.76 | 2.15M | 246,002 | D | ↗ |
| 2026-04-03 | Eck Steven W | Officer | A-Award | A | Common Stock | 31,645 | 0.00 | — | 130,978 | D | ↗ |
| 2026-03-10 | MEHRA SANJEEV K | Director | P-Purchase | A | Common Stock | 125,000 | 8.01 | 1.00M | 475,000 | I | ↗ |
| 2026-02-24 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 359 | 9.11 | 3.3K | 249,045 | D | ↗ |
| 2026-02-24 | Eck Steven W | Officer | F-InKind | D | Common Stock | 452 | 9.11 | 4.1K | 99,333 | D | ↗ |
| 2026-02-23 | Sokenu Claudius | Officer | F-InKind | D | Common Stock | 2,376 | 8.89 | 21.1K | 252,429 | D | ↗ |
| 2026-02-23 | Jones R. Brent | Officer | F-InKind | D | Common Stock | 2,805 | 8.89 | 24.9K | 419,782 | D | ↗ |
| 2026-02-23 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 1,324 | 8.89 | 11.8K | 249,404 | D | ↗ |
| 2026-02-23 | Gourdier Benoit | Officer | F-InKind | D | Common Stock | 3,029 | 8.89 | 26.9K | 362,859 | D | ↗ |
| 2026-02-23 | Eck Steven W | Officer | F-InKind | D | Common Stock | 2,017 | 8.89 | 17.9K | 99,785 | D | ↗ |
| 2026-02-20 | Walker Corey | Officer | F-InKind | D | Common Stock | 4,963 | 9.03 | 44.8K | 387,545 | D | ↗ |
| 2026-02-20 | Sokenu Claudius | Officer | F-InKind | D | Common Stock | 2,919 | 9.03 | 26.4K | 254,805 | D | ↗ |
| 2026-02-20 | Jones R. Brent | Officer | F-InKind | D | Common Stock | 9,506 | 9.03 | 85.8K | 422,587 | D | ↗ |
| 2026-02-20 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 1,453 | 9.03 | 13.1K | 250,728 | D | ↗ |
| 2026-02-20 | Gourdier Benoit | Officer | F-InKind | D | Common Stock | 4,160 | 9.03 | 37.6K | 365,888 | D | ↗ |
| 2026-02-20 | Eck Steven W | Officer | F-InKind | D | Common Stock | 2,125 | 9.03 | 19.2K | 101,802 | D | ↗ |
| 2026-02-19 | Walker Corey | Officer | A-Award | A | Common Stock | 161,237 | 0.00 | — | 392,508 | D | ↗ |
| 2026-02-19 | Sokenu Claudius | Officer | A-Award | A | Common Stock | 80,618 | 0.00 | — | 257,724 | D | ↗ |
| 2026-02-19 | Ligner Emmanuel | Director / Officer | A-Award | A | Common Stock | 483,713 | 0.00 | — | 767,137 | D | ↗ |
| 2026-02-19 | LUCIER GREGORY T | Director | P-Purchase | A | Common Stock | 50,000 | 9.16 | 458.0K | 50,000 | I | ↗ |
| 2026-02-19 | Jones R. Brent | Officer | A-Award | A | Common Stock | 161,237 | 0.00 | — | 432,093 | D | ↗ |
| 2026-02-19 | Hankamer Brittany | Officer | A-Award | A | Common Stock | 80,618 | 0.00 | — | 252,181 | D | ↗ |
| 2026-02-19 | Gourdier Benoit | Officer | A-Award | A | Common Stock | 134,364 | 0.00 | — | 370,048 | D | ↗ |
| 2026-02-19 | Eck Steven W | Officer | A-Award | A | Stock Options (Right to Buy) | 43,230 | 9.21 | 398.1K | 43,230 | D | ↗ |
| 2026-02-19 | Blenn Mary | Officer | A-Award | A | Common Stock | 235,993 | 0.00 | — | 253,384 | D | ↗ |
| 2026-02-12 | SUMME GREGORY L | Director | P-Purchase | A | Common Stock | 100,000 | 9.40 | 940.0K | 400,000 | I | ↗ |
| 2026-01-02 | Dingemans Simon | Director | A-Award | A | Common Stock | 6,225 | 0.00 | — | 6,225 | D | ↗ |
| 2025-12-05 | MEHRA SANJEEV K | Director | A-Award | A | Common Stock | 8,106 | 0.00 | — | 8,106 | D | ↗ |
| 2025-11-17 | Ligner Emmanuel | Director / Officer | P-Purchase | A | Common Stock | 87,500 | 11.35 | 993.1K | 283,424 | D | ↗ |
| 2025-11-10 | Blenn Mary | Officer | A-Award | A | Stock Options (Right to Buy) | 47,058 | 11.50 | 541.2K | 47,058 | D | ↗ |
| 2025-10-30 | SUMME GREGORY L | Director | P-Purchase | A | Common Stock | 100,000 | 11.25 | 1.13M | 300,000 | I | ↗ |
| 2025-10-03 | LUCIER GREGORY T | Director | A-Award | A | Common Stock | 8,736 | 0.00 | — | 8,736 | D | ↗ |
| 2025-10-02 | Gourdier Benoit | Officer | F-InKind | D | Common Stock | 1,264 | 13.77 | 17.4K | 235,684 | D | ↗ |
| 2025-08-21 | SUMME GREGORY L | Director | P-Purchase | A | Common Stock | 100,000 | 12.56 | 1.26M | 200,000 | I | ↗ |
| 2025-08-18 | Ligner Emmanuel | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 573,394 | 14.04 | 8.05M | 573,394 | D | ↗ |
| 2025-08-14 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 181 | 12.98 | 2.3K | 171,563 | D | ↗ |
| 2025-08-08 | Couturier Christophe | Officer | A-Award | A | Common Stock | 65,217 | 0.00 | — | 211,271 | D | ↗ |
| 2025-08-05 | Eck Steven W | Officer | S-Sale | D | Common Stock | 3,476 | 11.39 | 39.6K | 55,068 | D | ↗ |
| 2025-07-31 | Eck Steven W | Officer | F-InKind | D | Common Stock | 1,385 | 13.44 | 18.6K | 58,544 | D | ↗ |
| 2025-07-24 | Sokenu Claudius | Officer | F-InKind | D | Common Stock | 3,123 | 14.01 | 43.8K | 177,106 | D | ↗ |
| 2025-06-21 | Walker Corey | Officer | F-InKind | D | Common Stock | 2,730 | 13.57 | 37.0K | 231,271 | D | ↗ |
| 2025-05-23 | SUMME GREGORY L | Director | P-Purchase | A | Common Stock | 30,000 | 12.50 | 375.0K | 100,000 | I | ↗ |
| 2025-05-22 | SUMME GREGORY L | Director | P-Purchase | A | Common Stock | 20,000 | 12.65 | 253.0K | 70,000 | I | ↗ |
| 2025-05-21 | Stubblefield Michael | Director / Officer | G-Gift | D | Common Stock | 76,000 | 0.00 | — | 1,219,013 | D | ↗ |
| 2025-05-09 | Walker Corey | Officer | A-Award | A | Common Stock | 162,866 | 0.00 | — | 234,001 | D | ↗ |
| 2025-05-09 | Sokenu Claudius | Officer | A-Award | A | Common Stock | 122,149 | 0.00 | — | 180,229 | D | ↗ |
| 2025-05-09 | Jones R. Brent | Officer | A-Award | A | Common Stock | 162,866 | 0.00 | — | 269,676 | D | ↗ |
| 2025-05-09 | Hankamer Brittany | Officer | A-Award | A | Common Stock | 122,149 | 0.00 | — | 171,744 | D | ↗ |
| 2025-05-09 | Gourdier Benoit | Officer | A-Award | A | Common Stock | 162,866 | 0.00 | — | 236,948 | D | ↗ |
| 2025-05-09 | Eck Steven W | Officer | A-Award | A | Common Stock | 20,358 | 0.00 | — | 59,929 | D | ↗ |
| 2025-05-09 | Couturier Christophe | Officer | A-Award | A | Common Stock | 61,074 | 0.00 | — | 144,914 | D | ↗ |
| 2025-05-08 | SUMME GREGORY L | Director | A-Award | A | Common Stock | 17,100 | 0.00 | — | 58,111 | D | ↗ |
| 2025-05-08 | SEVERINO MICHAEL | Director | A-Award | A | Common Stock | 17,100 | 0.00 | — | 60,551 | D | ↗ |
| 2025-05-08 | Peacock Jonathan M | Director | A-Award | A | Common Stock | 17,100 | 0.00 | — | 219,815 | D | ↗ |
| 2025-05-08 | Murthy Mala | Director | A-Award | A | Common Stock | 17,100 | 0.00 | — | 44,209 | D | ↗ |
| 2025-05-08 | Massaro Joseph R | Director | A-Award | A | Common Stock | 17,100 | 0.00 | — | 52,138 | D | ↗ |
| 2025-05-08 | Makin Louise | Director | A-Award | A | Common Stock | 17,100 | 0.00 | — | 21,870 | D | ↗ |
| 2025-05-08 | Kang Lan | Director | A-Award | A | Common Stock | 17,100 | 0.00 | — | 52,315 | D | ↗ |
| 2025-05-08 | Carethers John | Director | A-Award | A | Common Stock | 17,100 | 0.00 | — | 45,858 | D | ↗ |
| 2025-05-08 | Andres Juan | Director | A-Award | A | Common Stock | 17,100 | 0.00 | — | 65,480 | D | ↗ |
| 2025-05-07 | SUMME GREGORY L | Director | P-Purchase | A | Common Stock | 25,000 | 12.00 | 300.0K | 50,000 | I | ↗ |
| 2025-04-29 | Massaro Joseph R | Director | P-Purchase | A | Common Stock | 8,100 | 12.30 | 99.6K | 35,038 | D | ↗ |
| 2025-04-28 | SUMME GREGORY L | Director | P-Purchase | A | Common Stock | 25,000 | 12.50 | 312.5K | 25,000 | I | ↗ |
| 2025-04-28 | Peacock Jonathan M | Director | P-Purchase | A | Common Stock | 8,091 | 12.81 | 103.6K | 202,715 | D | ↗ |
| 2025-04-28 | Kang Lan | Director | P-Purchase | A | Common Stock | 5,000 | 12.57 | 62.9K | 35,215 | D | ↗ |
| 2025-04-05 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 569 | 15.13 | 8.6K | 83,840 | D | ↗ |
| 2025-03-31 | Walker Corey | Officer | — | — | Common Stock | 0 | 0.00 | — | 71,135 | D | ↗ |
| 2025-02-27 | Eck Steven W | Officer | S-Sale | D | Common Stock | 1,033 | 17.00 | 17.6K | 39,571 | D | ↗ |
| 2025-02-27 | Bramwell James | Officer | S-Sale | D | Common Stock | 774 | 17.00 | 13.2K | 86,605 | D | ↗ |
| 2025-02-26 | Eck Steven W | Officer | S-Sale | D | Common Stock | 4,907 | 17.53 | 86.0K | 40,604 | D | ↗ |
| 2025-02-26 | Bramwell James | Officer | S-Sale | D | Common Stock | 3,758 | 17.53 | 65.9K | 87,379 | D | ↗ |
| 2025-02-25 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 4,969 | 17.56 | 87.3K | 1,448,022 | D | ↗ |
| 2025-02-25 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 369 | 17.56 | 6.5K | 49,595 | D | ↗ |
| 2025-02-25 | Eck Steven W | Officer | F-InKind | D | Common Stock | 505 | 17.56 | 8.9K | 45,511 | D | ↗ |
| 2025-02-25 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 556 | 17.56 | 9.8K | 84,409 | D | ↗ |
| 2025-02-25 | Bramwell James | Officer | F-InKind | D | Common Stock | 583 | 17.56 | 10.2K | 91,137 | D | ↗ |
| 2025-02-24 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 6,800 | 17.47 | 118.8K | 1,452,991 | D | ↗ |
| 2025-02-24 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 437 | 17.47 | 7.6K | 49,964 | D | ↗ |
| 2025-02-24 | Eck Steven W | Officer | F-InKind | D | Common Stock | 439 | 17.47 | 7.7K | 46,016 | D | ↗ |
| 2025-02-24 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 750 | 17.47 | 13.1K | 84,965 | D | ↗ |
| 2025-02-24 | Bramwell James | Officer | F-InKind | D | Common Stock | 2,181 | 17.47 | 38.1K | 91,720 | D | ↗ |
| 2025-02-23 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 14,674 | 17.30 | 253.9K | 1,459,791 | D | ↗ |
| 2025-02-23 | Sokenu Claudius | Officer | F-InKind | D | Common Stock | 2,318 | 17.30 | 40.1K | 58,080 | D | ↗ |
| 2025-02-23 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 1,537 | 17.30 | 26.6K | 50,401 | D | ↗ |
| 2025-02-23 | Gourdier Benoit | Officer | F-InKind | D | Common Stock | 2,842 | 17.30 | 49.2K | 74,082 | D | ↗ |
| 2025-02-23 | Eck Steven W | Officer | F-InKind | D | Common Stock | 1,956 | 17.30 | 33.8K | 46,455 | D | ↗ |
| 2025-02-23 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 1,506 | 17.30 | 26.1K | 85,715 | D | ↗ |
| 2025-02-23 | Bramwell James | Officer | F-InKind | D | Common Stock | 3,443 | 17.30 | 59.6K | 93,901 | D | ↗ |
| 2025-02-20 | Stubblefield Michael | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 380,886 | 17.49 | 6.66M | 380,886 | D | ↗ |
| 2025-02-20 | Sokenu Claudius | Officer | A-Award | A | Stock Options (Right to Buy) | 51,939 | 17.49 | 908.4K | 51,939 | D | ↗ |
| 2025-02-20 | Jones R. Brent | Officer | A-Award | A | Stock Options (Right to Buy) | 103,878 | 17.49 | 1.82M | 103,878 | D | ↗ |
| 2025-02-20 | Hankamer Brittany | Officer | A-Award | A | Stock Options (Right to Buy) | 41,551 | 17.49 | 726.7K | 41,551 | D | ↗ |
| 2025-02-20 | Gourdier Benoit | Officer | A-Award | A | Common Stock | 35,734 | 0.00 | — | 76,924 | D | ↗ |
| 2025-02-20 | Eck Steven W | Officer | A-Award | A | Common Stock | 18,867 | 0.00 | — | 48,411 | D | ↗ |
| 2025-02-20 | Couturier Christophe | Officer | A-Award | A | Common Stock | 12,864 | 0.00 | — | 87,221 | D | ↗ |
| 2024-11-04 | Makin Louise | Director | A-Award | A | Common Stock | 4,770 | 0.00 | — | 4,770 | D | ↗ |
| 2024-10-02 | Gourdier Benoit | Officer | F-InKind | D | Common Stock | 1,263 | 25.54 | 32.3K | 41,190 | D | ↗ |
| 2024-09-05 | Eck Steven W | Officer | S-Sale | D | Common Stock | 3,525 | 25.06 | 88.3K | 29,544 | — | ↗ |
| 2024-08-14 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 180 | 25.07 | 4.5K | 34,786 | — | ↗ |
| 2024-07-31 | Eck Steven W | Officer | F-InKind | D | Common Stock | 1,337 | 26.75 | 35.8K | 33,069 | — | ↗ |
| 2024-07-31 | Couturier Christophe | Officer | S-Sale | D | Common Stock | 100 | 28.00 | 2.8K | 73,930 | — | ↗ |
| 2024-07-30 | Couturier Christophe | Officer | S-Sale | D | Common Stock | 10,000 | 27.00 | 270.0K | 74,030 | — | ↗ |
| 2024-07-24 | Sokenu Claudius | Officer | F-InKind | D | Common Stock | 3,122 | 22.37 | 69.8K | 38,958 | — | ↗ |
| 2024-07-18 | Sahin Kitty | Officer | F-InKind | D | Common Stock | 3,931 | 20.74 | 81.5K | 42,274 | — | ↗ |
| 2024-06-21 | Walker Corey | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-09 | SUMME GREGORY L | Director | A-Award | A | Common Stock | 8,477 | 0.00 | — | 41,011 | — | ↗ |
| 2024-05-09 | SEVERINO MICHAEL | Director | A-Award | A | Common Stock | 8,477 | 0.00 | — | 43,451 | — | ↗ |
| 2024-05-09 | Peacock Jonathan M | Director | A-Award | A | Common Stock | 8,477 | 0.00 | — | 194,624 | — | ↗ |
| 2024-05-09 | Murthy Mala | Director | A-Award | A | Common Stock | 8,477 | 0.00 | — | 27,109 | — | ↗ |
| 2024-05-09 | Massaro Joseph R | Director | A-Award | A | Common Stock | 8,477 | 0.00 | — | 26,938 | — | ↗ |
| 2024-05-09 | Kang Lan | Director | A-Award | A | Common Stock | 8,477 | 0.00 | — | 30,215 | — | ↗ |
| 2024-05-09 | Carethers John | Director | A-Award | A | Common Stock | 8,477 | 0.00 | — | 28,758 | — | ↗ |
| 2024-05-09 | Andres Juan | Director | A-Award | A | Common Stock | 8,477 | 0.00 | — | 48,380 | — | ↗ |
| 2024-04-16 | Stone Randy Lee | Officer | F-InKind | D | Common Stock | 6,762 | 24.60 | 166.3K | 68,105 | — | ↗ |
| 2024-04-05 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 569 | 25.87 | 14.7K | 83,320 | — | ↗ |
| 2024-03-08 | Eck Steven W | Officer | S-Sale | D | Common Stock | 3,685 | 25.63 | 94.4K | 34,406 | — | ↗ |
| 2024-02-29 | Couturier Christophe | Officer | S-Sale | D | Common Stock | 13,074 | 24.53 | 320.7K | 83,889 | — | ↗ |
| 2024-02-29 | Bramwell James | Officer | S-Sale | D | Common Stock | 4,910 | 24.52 | 120.4K | 96,233 | — | ↗ |
| 2024-02-27 | Bramwell James | Officer | S-Sale | D | Common Stock | 6,203 | 24.49 | 151.9K | 101,143 | — | ↗ |
| 2024-02-25 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 7,685 | 24.35 | 187.1K | 1,111,751 | — | ↗ |
| 2024-02-25 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 369 | 24.35 | 9.0K | 23,673 | — | ↗ |
| 2024-02-25 | Eck Steven W | Officer | F-InKind | D | Common Stock | 505 | 24.35 | 12.3K | 26,387 | — | ↗ |
| 2024-02-25 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 467 | 24.35 | 11.4K | 87,723 | — | ↗ |
| 2024-02-25 | Bramwell James | Officer | F-InKind | D | Common Stock | 511 | 24.35 | 12.4K | 86,813 | — | ↗ |
| 2024-02-24 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 9,595 | 24.35 | 233.6K | 1,119,436 | — | ↗ |
| 2024-02-24 | Sahin Kitty | Officer | F-InKind | D | Common Stock | 1,059 | 24.35 | 25.8K | 33,885 | — | ↗ |
| 2024-02-24 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 437 | 24.35 | 10.6K | 24,042 | — | ↗ |
| 2024-02-24 | Eck Steven W | Officer | F-InKind | D | Common Stock | 438 | 24.35 | 10.7K | 26,892 | — | ↗ |
| 2024-02-24 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 648 | 24.35 | 15.8K | 88,190 | — | ↗ |
| 2024-02-24 | Bramwell James | Officer | F-InKind | D | Common Stock | 1,955 | 24.35 | 47.6K | 87,324 | — | ↗ |
| 2024-02-23 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 7,422 | 24.35 | 180.7K | 1,129,031 | — | ↗ |
| 2024-02-23 | Stone Randy Lee | Officer | A-Award | A | Common Stock | 25,667 | 0.00 | — | 74,867 | — | ↗ |
| 2024-02-23 | Sokenu Claudius | Officer | A-Award | A | Stock Options (Right to Buy) | 42,674 | 24.35 | 1.04M | 42,674 | — | ↗ |
| 2024-02-23 | Sahin Kitty | Officer | A-Award | A | Stock Options (Right to Buy) | 30,122 | 24.35 | 733.5K | 30,122 | — | ↗ |
| 2024-02-23 | Jones R. Brent | Officer | A-Award | A | Stock Options (Right to Buy) | 62,753 | 24.35 | 1.53M | 62,753 | — | ↗ |
| 2024-02-23 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 421 | 24.35 | 10.3K | 24,479 | — | ↗ |
| 2024-02-23 | Gourdier Benoit | Officer | A-Award | A | Common Stock | 25,667 | 0.00 | — | 42,453 | — | ↗ |
| 2024-02-23 | Eck Steven W | Officer | F-InKind | D | Common Stock | 422 | 24.35 | 10.3K | 27,330 | — | ↗ |
| 2024-02-23 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 416 | 24.35 | 10.1K | 88,838 | — | ↗ |
| 2024-02-23 | Bramwell James | Officer | F-InKind | D | Common Stock | 569 | 24.35 | 13.9K | 89,279 | — | ↗ |
| 2024-02-22 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 41,177 | 24.59 | 1.01M | 1,136,453 | — | ↗ |
| 2024-02-22 | Couturier Christophe | Officer | A-Award | A | Common Stock | 9,290 | 0.00 | — | 91,828 | — | ↗ |
| 2024-02-22 | Bramwell James | Officer | F-InKind | D | Common Stock | 2,842 | 24.59 | 69.9K | 89,848 | — | ↗ |
| 2024-02-20 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 9,711 | 24.05 | 233.5K | 1,078,555 | — | ↗ |
| 2024-02-20 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 289 | 24.05 | 7.0K | 24,900 | — | ↗ |
| 2024-02-20 | Eck Steven W | Officer | F-InKind | D | Common Stock | 435 | 24.05 | 10.5K | 27,752 | — | ↗ |
| 2024-02-20 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 1,392 | 24.05 | 33.5K | 82,538 | — | ↗ |
| 2024-02-20 | Bramwell James | Officer | F-InKind | D | Common Stock | 1,216 | 24.05 | 29.2K | 85,258 | — | ↗ |
| 2023-12-31 | Lewis Sheri | Officer | F-InKind | D | Common Stock | 4,556 | 22.83 | 104.0K | 70,692 | — | ↗ |
| 2023-10-02 | Gourdier Benoit | Officer | A-Award | A | Stock Options (Right to Buy) | 39,281 | 20.85 | 819.0K | 39,281 | — | ↗ |
| 2023-09-07 | Eck Steven W | Officer | S-Sale | D | Common Stock | 7,577 | 20.64 | 156.4K | 28,187 | — | ↗ |
| 2023-09-05 | Hankamer Brittany | Officer | F-InKind | D | Common Stock | 309 | 21.70 | 6.7K | 25,189 | — | ↗ |
| 2023-08-25 | Vanderhaegen Frederic | Officer | S-Sale | D | Common Stock | 25,000 | 21.47 | 536.8K | 160,735 | — | ↗ |
| 2023-08-23 | Hankamer Brittany | Officer | — | D | Stock Options (Right to Buy) | 7,022 | 21.12 | 148.3K | 0 | — | ↗ |
| 2023-08-07 | Jones R. Brent | Officer | A-Award | A | Stock Options (Right to Buy) | 295,559 | 20.76 | 6.14M | 295,559 | — | ↗ |
| 2023-07-31 | Eck Steven W | Officer | A-Award | A | Common Stock | 14,584 | 0.00 | — | 35,764 | — | ↗ |
| 2023-07-24 | Sokenu Claudius | Officer | A-Award | A | Stock Options (Right to Buy) | 32,929 | 22.84 | 752.1K | 32,929 | — | ↗ |
| 2023-07-18 | Sahin Kitty | Officer | F-InKind | D | Common Stock | 3,931 | 21.01 | 82.6K | 34,944 | — | ↗ |
| 2023-05-26 | Stubblefield Michael | Director / Officer | G-Gift | D | Common Stock | 40,000 | 0.00 | — | 1,032,937 | — | ↗ |
| 2023-05-17 | Vanderhaegen Frederic | Officer | F-InKind | D | Common Stock | 2,210 | 20.28 | 44.8K | 185,735 | — | ↗ |
| 2023-05-17 | Szlosek Thomas A | Officer | F-InKind | D | Common Stock | 23,261 | 20.28 | 471.7K | 77,489 | — | ↗ |
| 2023-05-17 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 106,200 | 20.28 | 2.15M | 1,172,937 | — | ↗ |
| 2023-05-17 | Miller Justin | Officer | F-InKind | D | Common Stock | 12,449 | 20.28 | 252.5K | 93,336 | — | ↗ |
| 2023-05-17 | Eck Steven W | Officer | F-InKind | D | Common Stock | 553 | 20.28 | 11.2K | 21,180 | — | ↗ |
| 2023-05-17 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 15,706 | 20.28 | 318.5K | 82,944 | — | ↗ |
| 2023-05-17 | Brophy Gerard | Officer | F-InKind | D | Common Stock | 19,683 | 20.28 | 399.2K | 89,032 | — | ↗ |
| 2023-05-17 | Bramwell James | Officer | F-InKind | D | Common Stock | 18,917 | 20.28 | 383.6K | 85,393 | — | ↗ |
| 2023-05-11 | Shaw Christi | Director | A-Award | A | Common Stock | 9,808 | 0.00 | — | 36,271 | — | ↗ |
| 2023-05-11 | SUMME GREGORY L | Director | A-Award | A | Common Stock | 9,808 | 0.00 | — | 32,534 | — | ↗ |
| 2023-05-11 | SEVERINO MICHAEL | Director | A-Award | A | Common Stock | 9,808 | 0.00 | — | 34,974 | — | ↗ |
| 2023-05-11 | Peacock Jonathan M | Director | A-Award | A | Common Stock | 9,808 | 0.00 | — | 186,147 | — | ↗ |
| 2023-05-11 | Murthy Mala | Director | A-Award | A | Common Stock | 9,808 | 0.00 | — | 18,632 | — | ↗ |
| 2023-05-11 | Massaro Joseph R | Director | A-Award | A | Common Stock | 9,808 | 0.00 | — | 18,461 | — | ↗ |
| 2023-05-11 | Kang Lan | Director | A-Award | A | Common Stock | 9,808 | 0.00 | — | 21,738 | — | ↗ |
| 2023-05-11 | Carethers John | Director | A-Award | A | Common Stock | 9,808 | 0.00 | — | 20,281 | — | ↗ |
| 2023-05-11 | Andres Juan | Director | A-Award | A | Common Stock | 9,808 | 0.00 | — | 39,903 | — | ↗ |
| 2023-04-16 | Stone Randy Lee | Officer | A-Award | A | Common Stock | 48,332 | 0.00 | — | 48,332 | — | ↗ |
| 2023-04-11 | Couturier Christophe | Officer | S-Sale | D | Common Stock | 1,498 | 21.18 | 31.7K | 98,650 | — | ↗ |
| 2023-04-05 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 569 | 20.82 | 11.8K | 100,148 | — | ↗ |
| 2023-03-03 | Brophy Gerard | Officer | S-Sale | D | Common Stock | 3,914 | 25.00 | 97.9K | 108,715 | — | ↗ |
| 2023-02-28 | Couturier Christophe | Officer | S-Sale | D | Common Stock | 2,324 | 24.32 | 56.5K | 100,717 | — | ↗ |
| 2023-02-27 | Brophy Gerard | Officer | S-Sale | D | Common Stock | 3,059 | 25.00 | 76.5K | 112,629 | — | ↗ |
| 2023-02-25 | Vanderhaegen Frederic | Officer | F-InKind | D | Common Stock | 299 | 24.62 | 7.4K | 187,945 | — | ↗ |
| 2023-02-25 | Szlosek Thomas A | Officer | F-InKind | D | Common Stock | 2,040 | 24.62 | 50.2K | 104,853 | — | ↗ |
| 2023-02-25 | Stubblefield Michael | Director / Officer | F-InKind | D | Common Stock | 7,685 | 24.62 | 189.2K | 1,279,137 | — | ↗ |
| 2023-02-25 | Miller Justin | Officer | F-InKind | D | Common Stock | 560 | 24.62 | 13.8K | 105,785 | — | ↗ |
| 2023-02-25 | Lewis Sheri | Officer | F-InKind | D | Common Stock | 1,340 | 24.62 | 33.0K | 75,248 | — | ↗ |
| 2023-02-25 | Henson Meghan | Officer | F-InKind | D | Common Stock | 800 | 24.62 | 19.7K | 40,184 | — | ↗ |
| 2023-02-25 | Eck Steven W | Officer | F-InKind | D | Common Stock | 505 | 24.62 | 12.4K | 21,733 | — | ↗ |
| 2023-02-25 | Couturier Christophe | Officer | F-InKind | D | Common Stock | 467 | 24.62 | 11.5K | 103,041 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-20.1K
Shares Outstanding
682.76M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Michael Stubblefield Former Chief Executive Officer | 1.14M | — | 8.13M | 2.75M | 1.02M | 39.4K | 13.08M | 83.16% | ↗ |
| 2 | 2025 | R. Brent Jones Executive Vice President and Chief Financial Officer | 653.3K | — | 4.82M | 750.0K | 272.3K | 39.4K | 6.54M | 85.24% | ↗ |
| 3 | 2025 | Corey Walker President Laboratory Solutions | 700.0K | — | 4.17M | 750.0K | 322.8K | 41.3K | 5.99M | 82.23% | ↗ |
| 4 | 2025 | Emmanuel Ligner Director, President and Chief Executive Officer | 379.3K | — | 2.50M | 2.50M | 330.0K | 186.3K | 5.90M | 84.81% | ↗ |
| 5 | 2025 | Benoit Gourdier Executive Vice President Bioscience Production | 550.0K | — | 3.80M | 625.0K | 215.9K | 30.1K | 5.23M | 84.77% | ↗ |
| 6 | 2025 | Claudius Sokenu Executive Vice President, Chief Legal and Compliance Officer | 550.0K | — | 2.58M | 375.0K | 208.3K | 40.3K | 3.75M | 78.70% | ↗ |
| 7 | 2024 | Michael Stubblefield Former Chief Executive Officer | 1.13M | — | 8.65M | 2.63M | 2.09M | 37.6K | 14.53M | 77.63% | ↗ |
| 8 | 2024 | R. Brent Jones Executive Vice President and Chief Financial Officer | 611.5K | — | 2.06M | 625.0K | 554.2K | 35.9K | 3.89M | 69.08% | ↗ |
| 9 | 2024 | Benoit Gourdier Executive Vice President Bioscience Production | 516.1K | — | 2.06M | 625.0K | 512.2K | 20.0K | 3.73M | 71.92% | ↗ |
| 10 | 2024 | Claudius Sokenu Executive Vice President, Chief Legal and Compliance Officer | 543.7K | — | 1.40M | 425.0K | 431.7K | 31.8K | 2.83M | 64.45% | ↗ |
| 11 | 2023 | Michael Stubblefield Director, President and Chief Executive Officer | 1.14M | — | 8.53M | 2.44M | 188.1K | 44.4K | 12.34M | 88.88% | ↗ |
| 12 | 2023 | Michael Stubblefield Former Chief Executive Officer | 1.14M | — | 8.53M | 2.44M | 188.1K | 44.4K | 12.34M | 88.88% | ↗ |
| 13 | 2023 | R. Brent Jones Executive Vice President and Chief Financial Officer | 221.2K | 200.0K | 2.82M | 2.56M | 18.5K | 22.0K | 5.84M | 92.10% | ↗ |
| 14 | 2023 | Randy Stone Executive Vice President Proprietary Products | 415.4K | — | 2.11M | 2.00M | 34.2K | 33.2K | 4.59M | 89.48% | ↗ |
| 15 | 2023 | Frederic Vanderhaegen Executive Vice President Europe | 618.2K | — | 1.75M | 499.9K | 52.8K | 122.9K | 3.04M | 73.91% | ↗ |
| 16 | 2023 | Gerard Brophy Former Executive Vice President, Biopharma Production | 575.0K | — | 1.75M | 499.9K | 46.0K | 37.1K | 2.91M | 77.36% | ↗ |
| 17 | 2023 | Thomas Szlosek Former Executive Vice President and Chief Financial Officer | 369.2K | — | 1.92M | 549.9K | — | 39.2K | 2.88M | 85.83% | ↗ |
| 18 | 2023 | James Bramwell Executive Vice President, Americas | 498.0K | — | 1.75M | 499.9K | 39.4K | 53.4K | 2.84M | 79.20% | ↗ |
| 19 | 2022 | Michael Stubblefield Director, President and Chief Executive Officer | 1.13M | — | 7.37M | 2.31M | — | 19.5K | 10.83M | 89.41% | ↗ |
| 20 | 2022 | Thomas Szlosek Executive Vice President and Chief Financial Officer | 600.0K | — | 1.75M | 550.3K | — | 20.4K | 2.92M | 78.78% | ↗ |
| 21 | 2022 | Thomas Szlosek Former Executive Vice President and Chief Financial Officer | 600.0K | — | 1.75M | 550.3K | — | 20.4K | 2.92M | 78.78% | ↗ |
| 22 | 2022 | Frederic Vanderhaegen Executive Vice President Europe | 577.7K | — | 1.59M | 500.2K | — | 88.5K | 2.76M | 75.87% | ↗ |
| 23 | 2022 | Gerard Brophy Executive Vice President Biopharma Production | 563.5K | — | 1.59M | 500.2K | — | 19.1K | 2.68M | 78.23% | ↗ |
| 24 | 2022 | Gerard Brophy Former Executive Vice President, Biopharma Production | 563.5K | — | 1.59M | 500.2K | — | 19.1K | 2.68M | 78.23% | ↗ |
| 25 | 2022 | Sheri Lewis Executive Vice President, Global Operations & Supply Chain | 475.0K | — | 1.04M | 325.1K | — | 15.6K | 1.85M | 73.51% | ↗ |
| 26 | 2021 | Michael Stubblefield Director, President and Chief Executive Officer | 1.09M | — | 6.63M | 2.00M | 3.52M | 19.6K | 13.26M | 65.10% | ↗ |
| 27 | 2021 | Thomas Szlosek Executive Vice President and Chief Financial Officer | 600.0K | — | 1.49M | 450.0K | 1.77M | 22.3K | 4.34M | 44.80% | ↗ |
| 28 | 2021 | Thomas Szlosek Former Executive Vice President and Chief Financial Officer | 600.0K | — | 1.49M | 450.0K | 1.77M | 22.3K | 4.34M | 44.80% | ↗ |
| 29 | 2021 | Frederic Vanderhaegen Executive Vice President Europe | 579.7K | — | 1.49M | 450.0K | 962.7K | 80.2K | 3.57M | 54.49% | ↗ |
| 30 | 2021 | Frederic Vanderhaegen Executive Vice President Americas & Europe | 579.7K | — | 1.49M | 450.0K | 962.7K | 80.2K | 3.57M | 54.49% | ↗ |
| 31 | 2021 | Gerard Brophy Executive Vice President Biopharma Production | 513.5K | — | 1.49M | 450.0K | 862.4K | 20.6K | 3.34M | 58.18% | ↗ |
| 32 | 2021 | Gerard Brophy Former Executive Vice President, Biopharma Production | 513.5K | — | 1.49M | 450.0K | 862.4K | 20.6K | 3.34M | 58.18% | ↗ |
| 33 | 2021 | Sheri Lewis Executive Vice President, Global Operations & Supply Chain | 469.5K | 250.0K | 1.24M | 375.0K | 560.9K | 14.9K | 2.91M | 55.55% | ↗ |
| 34 | 2020 | Michael Stubblefield Director, President and Chief Executive Officer | 1.09M | — | 4.81M | 2.50M | 2.37M | 486.0K | 11.26M | 64.97% | ↗ |
| 35 | 2020 | Thomas Szlosek Executive Vice President and Chief Financial Officer | 600.0K | — | 2.41M | 1.85M | 1.37M | 17.1K | 6.24M | 68.15% | ↗ |
| 36 | 2020 | Frederic Vanderhaegen Executive Vice President Europe | 495.5K | — | 1.96M | 1.50M | 615.5K | 64.3K | 4.64M | 74.66% | ↗ |
| 37 | 2020 | Frederic Vanderhaegen Executive Vice President Americas & Europe | 495.5K | — | 1.96M | 1.50M | 615.5K | 64.3K | 4.64M | 74.66% | ↗ |
| 38 | 2020 | Gerard Brophy Executive Vice President Biopharma Production | 474.7K | — | 1.83M | 1.43M | 519.2K | 17.3K | 4.28M | 76.37% | ↗ |
| 39 | 2020 | Michael Wondrasch Executive Vice President, Chief Information Officer | 399.7K | — | 1.33M | 1.05M | 397.5K | 17.5K | 3.19M | 74.48% | ↗ |
| 40 | 2019 | Michael Stubblefield Director, President and Chief Executive Officer | 984.3K | 130.0K | 14.00M | — | 1.28M | 598.7K | 17.00M | 82.38% | ↗ |
| 41 | 2019 | Ashish Kulkarni Executive Vice President and Chief Technology Officer | 400.0K | 737.0K | 1.80M | — | — | 2.13M | 5.07M | 35.52% | ↗ |
| 42 | 2019 | Thomas Szlosek Executive Vice President and Chief Financial Officer | 600.0K | — | 2.60M | — | 765.0K | 12.1K | 3.98M | 65.37% | ↗ |
| 43 | 2019 | Devashish Ohri Executive Vice President, IMEA | 366.8K | — | 2.20M | — | 92.1K | 633.4K | 3.29M | 66.82% | ↗ |
| 44 | 2019 | Bjorn Hofman Executive Vice President and Chief Operating Officer | 450.0K | — | 2.20M | — | 244.8K | 154.0K | 3.05M | 72.16% | ↗ |
| 45 | 2018 | Thomas Szlosek Executive Vice President and Chief Financial Officer | 46.2K | 225.0K | — | 7.13M | — | — | 7.40M | 96.34% | ↗ |
| 46 | 2018 | Gerard Brophy Executive Vice President Biopharma Production | 184.0K | — | — | 3.16M | 168.2K | 5.4K | 3.52M | 89.85% | ↗ |
| 47 | 2018 | Frederic Vanderhaegen Executive Vice President Americas & Europe | 86.2K | — | — | 2.88M | 125.0K | 3.2K | 3.10M | 93.08% | ↗ |
| 48 | 2018 | Bjorn Hofman Executive Vice President and Chief Operating Officer | 450.0K | — | — | — | 414.0K | 2.05M | 2.91M | 0.00% | ↗ |
| 49 | 2018 | Michael Stubblefield Director, President and Chief Executive Officer | 700.0K | 130.0K | — | — | 1.61M | 282.3K | 2.72M | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Corey D. Walker | President of Laboratory Solutions | 1M | male |
| R. Brent Jones | Executive Vice President & Chief Financial Officer | 964.9K | male |
| Emmanuel Ligner | President, Chief Executive Officer & Director | 895.6K | male |
| Michael Wondrasch | Executive Vice President & Chief Information Officer | 808.6K | male |
| Claudius O. Sokenu | Executive Vice President, Corporate Secretary and Chief Legal & Compliance Officer | 798.6K | male |
| Benoit Gourdier | Executive Vice President of Bioscience Production | 796.0K | male |
| Christophe Couturier | Executive Vice President of AMEA | — | male |
| Justin Miller | Executive Vice President, Gen. Counsel & Sec. | — | male |
| Mary Blenn | Executive Vice President & Chief Operating Officer | — | female |
| Chris Fidyk | Vice President of Investor Relations | — | male |
| Brittany Hankamer | Executive Vice President & Chief Human Resources Officer | — | female |
| Steven W. Eck | Senior Vice President, Corporate Controller & Chief Accounting Officer | — | male |
ESG Rating
ESG Score History CHEMICALS - SPECIALTY
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-08-13 | 2025-09-12 | Gilbert Cisneros | CA31 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2025-08-12 | 2025-09-12 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2025-07-23 | 2025-08-15 | Gilbert Cisneros | CA31 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-06-17 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2025-06-11 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2024-09-10 | 2024-10-08 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2024-09-04 | 2024-09-06 | John James | MI10 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2023-11-10 | 2024-09-02 | John James | MI10 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-10-26 | 2023-11-08 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-10-25 | 2023-11-08 | Ro Khanna | CA17 | Spouse | Sale | $15,001 - $50,000 | ↗ |
| 2023-10-25 | 2023-11-08 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-10-17 | 2023-11-08 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-10-13 | 2023-11-08 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-10-12 | 2023-11-08 | Ro Khanna | CA17 | Spouse | Sale | $15,001 - $50,000 | ↗ |
| 2023-07-12 | 2023-08-13 | Daniel Goldman | NY10 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-06-28 | 2023-07-11 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-06-23 | 2023-07-11 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-06-15 | 2023-07-11 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-06-13 | 2023-07-11 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-05-23 | 2023-06-12 | Ro Khanna | CA17 | Spouse | Sale | $15,001 - $50,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AVTR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
